S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Shionogi & Co., Ltd. (SGIOY) News Today

$11.44
-0.02 (-0.17%)
(As of 04/18/2024 ET)
SourceHeadline
MarketBeat logoShionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Up 96.9% in March
americanbankingnews.com - April 12 at 4:26 AM
seekingalpha.com logoSGIOY Shionogi & Co., Ltd.
seekingalpha.com - March 18 at 11:48 PM
marketbeat.com logoShort Interest in Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Grows By 236.1%
marketbeat.com - March 12 at 11:53 PM
marketbeat.com logoShionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Update
marketbeat.com - March 1 at 6:51 PM
wsj.com logoShionogi & Co. Ltd. ADR
wsj.com - February 15 at 3:39 PM
uk.investing.com logoShionogi & Co., Ltd. (4507)
uk.investing.com - February 1 at 12:28 PM
marketbeat.com logoShionogi & Co., Ltd. (OTCMKTS:SGIOY) Releases Quarterly Earnings Results, Misses Estimates By $0.11 EPS
marketbeat.com - February 1 at 9:31 AM
markets.businessinsider.com logoHere's what to expect from Shionogi's earnings
markets.businessinsider.com - February 1 at 7:28 AM
msn.com logoShionogi & Co. GAAP EPS of ¥435.74, revenue of ¥336.82B
msn.com - February 1 at 7:28 AM
marketbeat.com logoShionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Down 57.4% in December
marketbeat.com - January 13 at 11:52 PM
msn.com logoShionogi commences Phase III monovalent Covid-19 vaccine trial
msn.com - December 18 at 3:36 PM
msn.com logoShionogi & Co. - ADR (SGIOY) Price Target Increased by 14.91% to 16.05
msn.com - December 17 at 10:26 AM
benzinga.com logoApnimed Announces Launch of Joint Venture with Shionogi to Develop Novel Pharmacologic Therapies for Obstructive Sleep Apnea and other Sleep Disorders
benzinga.com - November 1 at 8:22 PM
finance.yahoo.com logoShionogi & Co., Ltd. (SGIOF)
finance.yahoo.com - September 9 at 9:59 AM
finanznachrichten.de logoShionogi USA: IDWeek 2023: Shionogi and Qpex Biopharma, Inc. Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease
finanznachrichten.de - September 7 at 4:39 PM
msn.com logoDaiichi COVID vaccine endorsed in Japan; Shionogi’s shot declined
msn.com - August 1 at 3:53 PM
finance.yahoo.com logoShionogi Further Extends Infectious Disease Innovation Platform with Planned Acquisition of Qpex Biopharma, Inc.
finance.yahoo.com - June 26 at 2:53 PM
msn.com logoShionogi starts clinical trial for its 2nd oral coronavirus drug
msn.com - May 17 at 1:23 PM
marketwatch.com logoECCMID 2023: Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatment
marketwatch.com - April 5 at 8:34 AM
marketbeat.com logoJefferies Financial Group Comments on Shionogi & Co., Ltd.'s FY2023 Earnings (OTCMKTS:SGIOY)
marketbeat.com - March 15 at 2:26 AM
marketbeat.com logoShionogi & Co., Ltd. (OTCMKTS:SGIOY) Expected to Post FY2023 Earnings of $1.06 Per Share
marketbeat.com - March 13 at 2:17 AM
yahoo.com logoShionogi’s Antibiotic, FETCROJA® (cefiderocol), Is Now Available in the Netherlands
yahoo.com - February 22 at 9:31 PM
nz.finance.yahoo.com logoShionogi’s Innovative Antibiotic, FETCROJA® (cefiderocol), Is Now Available in Norway
nz.finance.yahoo.com - January 17 at 9:05 PM
finance.yahoo.com logoShionogi & Co., Ltd. Unsponsored ADR (SGIOY) Upgraded to Buy: Here's Why
finance.yahoo.com - December 26 at 2:53 PM
yahoo.com logoKaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 Drug
yahoo.com - November 29 at 11:08 AM
news.yahoo.com logoShionogi seeks Japan approval for COVID-19 vaccine
news.yahoo.com - November 24 at 10:58 AM
yahoo.com logoLeading Japanese Pharmaceutical Company, Shionogi, Officially Opens Doors of Its New European Headquarters in Amsterdam
yahoo.com - November 23 at 6:50 AM
finance.yahoo.com logoJapan Approves First Homegrown Covid-19 Antiviral Pill
finance.yahoo.com - November 22 at 7:31 AM
news.yahoo.com logoJapan's Shionogi shares jump after report of COVID drug gaining efficacy approval
news.yahoo.com - November 22 at 12:28 AM
benzinga.com logoOrsoBio Acquires Phase 2-Ready, Selective ACC2 Inhibitor from Shionogi & Co., Ltd. for the Treatment of Type 2 Diabetes
benzinga.com - November 2 at 9:33 PM
finance.yahoo.com logoShionogi & Co., Ltd. (SGIOY)
finance.yahoo.com - September 29 at 10:57 PM
seekingalpha.com logoShionogi says COVID pill resolves Omicron symptoms faster, meets trial's goal
seekingalpha.com - September 28 at 9:57 AM
usnews.com logoJapan's Shionogi Says COVID Pill Reaches Phase III Milestone
usnews.com - September 28 at 4:56 AM
msn.com logoShionogi confirms efficacy of oral COVID drug for Omicron subvariant
msn.com - August 10 at 3:24 AM
seekingalpha.com logoShionogi & Co. GAAP EPS of ¥115.13, revenue of ¥71.84B
seekingalpha.com - August 3 at 7:19 PM
investing.com logoShionogi & Co Ltd ADR (SGIOY)
investing.com - August 2 at 11:16 PM
benzinga.com logoShionogi Begins Phase 3 Study in Japan of Akili's Digital Treatment in Children with ADHD
benzinga.com - August 1 at 12:13 PM
marketwatch.com logoShionogi Shares Slump After Japan Panel Rejects Emergency Approval for Company's Covid-19 Drug
marketwatch.com - July 20 at 9:30 PM
seekingalpha.com logoShionogi faces setback for COVID pill as Japan delays authorization again
seekingalpha.com - July 20 at 11:27 AM
apnews.com logoShionogi Announces Strategic Re-Organization of U.S. Executive Leadership
apnews.com - June 1 at 5:46 PM
seekingalpha.com logoShionogi says oral COVID-19 therapy rapidly cleared virus in mid-stage trial
seekingalpha.com - April 25 at 8:30 AM
news.yahoo.com logoJapan's Shionogi says COVID-19 pill shows rapid clearance of virus
news.yahoo.com - April 24 at 12:06 PM
seekingalpha.com logoPfizer set to add nearly $24 billion revenue with COVID-19 pill - Airfinity
seekingalpha.com - April 22 at 6:37 PM
reuters.com logoUPDATE 2-Shionogi shares plunge on concerns over COVID pill risk to pregnancies
reuters.com - April 13 at 9:48 AM
nasdaq.com logoShionogi shares plunge 15% on report of COVID pill birth defect risk
nasdaq.com - April 13 at 1:58 AM
markets.businessinsider.com logoShionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticals
markets.businessinsider.com - April 6 at 12:44 PM
seekingalpha.com logoShionogi gets FDA nod to begin phase 3 study of oral COVID drug S-217622
seekingalpha.com - March 16 at 11:53 AM
bloomberg.com logoShionogi Says Covid-19 Vaccine Found Effective and Safe in Study
bloomberg.com - March 4 at 5:50 AM
seekingalpha.com logoShionogi files for approval of COVID-19 oral drug in Japan
seekingalpha.com - February 25 at 9:03 AM
news.yahoo.com logoJapan's Shionogi seeks approval for COVID-19 pill
news.yahoo.com - February 25 at 1:28 AM
Get Shionogi & Co., Ltd. News Delivered to You Automatically

Sign up to receive the latest news and ratings for SGIOY and its competitors with MarketBeat's FREE daily newsletter.

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

SGIOY Media Mentions By Week

SGIOY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SGIOY
News Sentiment

1.94

0.53

Average
Medical
News Sentiment

SGIOY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SGIOY Articles
This Week

1

0

SGIOY Articles
Average Week

Get Shionogi & Co., Ltd. News Delivered to You Automatically

Sign up to receive the latest news and ratings for SGIOY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:SGIOY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners